IVD

Liquid Biopsy’s Saga Continues with New Financing

The Lund, Sweden-based company raised $4.1 million to accelerate commercialization of its portfolio of kits and services.

Liquid Biopsy Tests Are Becoming More Mainstream

An industry executive talks about how the market is shifting toward broader acceptance of liquid biopsy tests.

Meet Thrive: The New Kid on the Liquid Biopsy Block

Thrive Earlier Detection Corp. has raised $110 million in a series A financing and has a launch similar to Grail’s introduction into the liquid biopsy market.

Could Myriad’s New Study Results Be Game Changers For Cancer Patients?

The Salt Lake City, UT-based company made a big showing at the 2019 American Society of Clinical Oncology meeting, presenting data from three key studies.

Quest Diagnostics Data Breach Could Impact Nearly 12M Customers

The Secaucus, NJ -based company said that sometime between August 1, 2018 and March 30, 2019, an unauthorized user breached AMCA, its billing collections vendor.

Grail Presents Early Favorable CCGA Data at ASCO

Results from the Circulating Cell-free Genome Atlas study show the Menlo Park, CA-based company’s solution detected a strong signal for 12 deadly cancer types at early stages with a very high specificity of at least 99%.

Resolution Bioscience Granted Breakthrough Device Designation from FDA

The Kirkland, WA-based company has been developing the Resolution HRD liquid biopsy test for about three years now.

That's a First: FDA Tackles STDs, Zika, and Prosthetic Joint Infection

FDA announced three diagnostic firsts dealing with sexually transmitted diseases, the Zika virus, and prosthetic joint infections.

How Exact Sciences Reinvented Itself

The Madison, WI-based company’s CEO spoke with MD+DI about the company’s past, present, future.

The Best Colon Cancer Screening Test Is the One That Gets Done

Data presented at Digestive Disease Week 2019 suggests that more people are willing to take a blood test than a stool test to screen for colorectal cancer.

Grail Sets Fast Pace in Liquid Biopsy with New Milestones

The Menlo Park, CA-based company has been granted Break Through Device Designation by FDA, in addition, the company will share new data from the Circulating Cell-free Genome Atlas, at ASCO.

How POC Diagnostics Are Becoming the Norm

Point-of-Care diagnostics are more common place as consumer demand is increasing in healthcare.

Medical Design Excellence Awards 2019 Finalists: Testing and Diagnostic Products and Systems

The following are the finalists for the Testing and Diagnostic Products and Systems category.

10 Deals That Shook up the Diagnostics Industry

MD+DI looks at 10 deals that fundamentally changed the diagnostics industry.

NGS and IVD Manufacturer Team up to Improve Clinical Trials

Cellgen Diagnostics and Genomic Testing Cooperative announced a collaboration that promises to provide the pharmaceutical industry with the seamless integration of biomarker discovery, validation, and IVD development.

Collaboration Leads to Blood-Based Concussion and TBI Test

If Chembio Diagnostics and Perseus Science Group are able to get a test on the market, the two would directly compete against Banyan Biomarkers, a company that received a nod from FDA for a concussion test platform last year.

Qmed Search Form